갑상샘종양의 감별진단에서 Galectin-3, Cytokeratin 19, p53, Ki-67의 유용성

참고문헌 (28)

1. "Diagnostic histopathology of tumors. 2nd ed", 981 (2000)
2. "Galectin-3 and HBME-1 expression in well-differentiated thyroid tumorswith follicular architecture of uncertain malignant potential", 18, pp.541~546 (2005)
3. "Galectin-3, fibronectin-1, CITED-1, HBME1 and cytokeratin-19 immunohistochemistry is useful for the diagnosis of thyroidtumors", pp.48~57 (2005)
4. "Galectin-3 expression in papillarymicrocarcinoma of the thyroid", 47, pp.209~214 (2005)
5. "Characterization ofthyroid ‘follicular neoplasms’ in fine-needle aspiration cytologicalspecimens using a panel of immunohistochemical markers:a proposalfor clinical application", 12, pp.305~317 (2005)
6. "Human galectin-3 immunoexpressionin thyroid follicular adenomas with cell atypia", 28, pp.106~112 (2005)
7. "The use of a combination of galectin-3 and thyroid peroxidase forthe diagnosis and prognosis of thyroid cancer", 122, pp.524~531 (2004)
8. "Galectin-3 in differentialdiagnosis and prognosis of follicular tumors of the thyroid gland", 66, pp.39~42 (2004)
9. "Diagnostic valueof galectin-3 as a marker for malignancy in follicular patterned thyroidlesions", 26, pp.960~966 (2004)
10. "Galectin-3:presurgicalmarker of thyroid follicular epithelial cell-derived carcinomas", 27, pp.311~317 (2004)
11. "The investigationof galectin-3 in diseases of the thyroid gland", 149, pp.449~453 (2003)
12. "Cytokeratin 19 and galectin-3 immunohistochemistryin the differential diagnosis of solitary thyroid nodules", 41, pp.236~243 (2002)
13. "Galectin-3 does not reliablydistinguish benign from malignant thyroid neoplasms", 45, pp.493~500 (2004)
14. "Low galectin-3 capacity to discriminate thyroid lesions", 56, pp.623~628 (2004)
15. "Usefulness of galectin-3 immunohistochemistry in differential diagnosis between thyroid follicular carcinoma and follicular adenoma", 54, pp.111~115 (2003)
16. "Analysis of P53 and P21WAF1 proteins expression in follicular thyroid tumors", 55, pp.133~141 (2004)
17. "Role of p53,CD44V6 and CD57 in differentiating between benign and malignant follicular neoplasms of the thyroid", 18, pp.189~195 (2004)
18. "Immunoreactivity of p53,Ki-67,and Bcl-2 in oncocytic adenomas and carcinomas of the thyroid gland", 30, pp.926~933 (1999)
19. "Immunohistochemical expression of Bcl-2,Ki-67,and p21 in patients with papillary thyroid cancer", 26, pp.50~56 (2005)
20. "Assessment of proliferative activity of thyroid Hurthle cell tumors using PCNA,Ki-67 and AgNOR methods", 42, pp.165~168 (2004)
21. "Immunohistochemical analysis of expression of bcl-2 protein in papillary carcinomas and papillary microcarcinomas of the thyroid gland", 26, pp.282~286 (2004)
22. "Significance of p53,cyclin D1 and c-myc expressions in thyroid tumors", 38, pp.29~34 (2004)
23. "Ki-67 labelling index and bax expression according to the capsular invasion in the follicular neoplasms of the thyroid", 35, pp.531~535 (2001)
24. "Robbins and Cotran pathologic basis of disease. 7th ed", pp.302~303 (2005)
25. "Rosai and Ackerman’s surgical pathology. 9th ed", pp.65~66 (2004)
26. "Distinct pattern of ret oncogene rearrangements in morphological variants of radiation-induced and sporadic thyroid papillary carcinomas in children", 57, pp.1690~1694 (1997)
27. "RET activationin in adult and childhood papillary thyroid carcinoma using a reverse transcriptase-n-polymerase chain reaction approach on archival-nested material", 74, pp.585~589 (1996)
28. "Mutational activation of BRAF is not a major event in sporadic childhood papillary thyroid carcinoma", 18, pp.898~902 (2005)

관련 논문AI추천